Campylobacter mucosalis

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Campylobacter mucosalis is a Gram-negative, non-spore-forming, microaerophilic, motile, rod-shaped - curved bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. The DNA G+C content is 36-38%. Campylobacter mucosalis is probably a rare gut coloniser. (VanDamme2005Bergey; Lawson1981; Roop1985)



  • This organism has been recovered from pig faeces. Has also been detected in human faeces (Bilen2018e). The risk classification (www.baua.de) for this organism is 2, i.e., risk of individual infection, but low risk of spread (notes: opportunistic in immunocompromised patients). Pathogenicity status unknown, or very unlikely to be pathogenic. A possible gut commensal.
    • GENERAL CHARACTERISTICS (VanDamme2005Bergey); (Lawson1981); (Roop1985);
    Character Response
  • 🧂
  • Salt tolerance:
  • doesn't tolerate 1.5% salt;
  • 🌡
  • Temperature tolerance:
  • grows at 25℃; grows at 42℃;
  • ⥅
  • Substrates assimilated or utilised:
  • formate; lactate; succinate;
  • Active enzymes:
  • oxidase;
    • SPECIAL FEATURES (VanDamme2005Bergey); (Roop1985);
    Character Response
  • ✓
  • Metabolites produced:
  • Hâ‚‚S;
  • ✓
  • Nitrate:
  • reduced
  • ✓
  • NO3➔NO2:
  • reduced
  • Pigments:
  • yellow
    • RESPONSE TO ANTIBIOTICS (VanDamme2005Bergey); (Roop1985);
    Class Active Resistant
  • Penicillins:
  • amoxicillin-clavulanic acid; meropenem; piperacillin-tazobactam; ticarcillin-clavulanic acid;
  • Cephalosporins:
  • ceftizoxime; cephalothin;
  • Macrolides:
  • azithromycin; erythromycin;
  • Tetracyclines:
  • minocycline;
  • Quinolines:
  • nalidixic-acid;
  • Aminoglycosides:
  • kanamycin; streptomycin;
  • neomycin;
  • Polypep/ketides:
  • bacitracin;
  • Heterocycles:
  • metronidazole;
  • Vancomycins:
  • vancomycin;
  • Miscellaneous antibiotics:
  • clindamycin; colistin; polymyxin B;

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Proteobacteria Class:  Epsilonproteobacteria Order:  Campylobacterales Family:  Campylobacteraceae Genus:  Campylobacter Gram stain:  neg O2 Relation.:  microaerophilic Spore:  No spore Motility:  Swimming Morphology:  Rod - curved Pigment:  yellow
    Health:  Unknown
    Source:  pig faeces. Has also been detected in human faeces (Bilen2018e)
    DNA G+C(%):  36-38
    Lower T(℃):  25(+)
    High T(℃):  42(+)
    NaCl 0.5-2%:  1.5(neg)
    		DNA:  neg Hippurate:  neg
    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    Formate:  + Lactate:  + Succinate:  +
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  + Catalase:  neg DNAse:  neg
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    		H2S:  + Pigment:  yellow
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    Augmentin:  SensRNG: (0.06-0.5)
    penicillin:  RNG: (1-32)
    piperacillin:  RNG: (2-26)
    piper-taz:  SensRNG: (0.016-4)
    tica-clav:  S(0.016)
    meropenem:  S(0.03)
    cefoxitin:  RNG: (1-16
    ceftizoxime:  SensRNG: (0.25-1)
    cephalothin:  S(30; disc)
    gentamicin:  Var(MIC50): 2-4), MIC90: Var(2-4
    kanamycin:  SensRNG: (<0.5-2)
    neomycin:  R(16-32)
    streptomycin:  SensRNG: (1-2)
    azithromycin:  SensRNG: (≤0.03-0.5)
    erythromycin:  SensRNG: (1-2)
    nalidixic-acid:  R(16->128)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    minocycline:  SensRNG: (<0.5-2)
    tetracycline:  RNG: (1-8)
    vancomycin:  R(>128)
    bacitracin:  R(>128)
    rifampicin:  RNG: (4-32)
    chloramphenicol:  RNG: (2-8)
    metronidazole:  SensRNG: (0.12-1)
    clindamycin:  SensRNG: (0.25-0.5)
    colistin:  SensRNG: (0.5-1)
    polymyxin_B:  SensRNG: (<0.25-1)

    References

    SPECIFIC REFERENCES FOR CAMPYLOBACTER MUCOSALIS
  • VanDamme2005Bergey - Bergey's manual of systematic bacteriology. Vol. 2, The Alpha-, Beta-, Delta-, and Epsilonproteobacteria Part C. Family Campylobacteraceae, Genus I. Campylobacter
  • Lawson1974 - Intestinal adenomatosis in the pig: a bacteriological study.
  • Vandamme2001 - Recommendations of the subcommittee on the taxonomy of Campylobacter and related bacteria.
  • Lawson1981 - Some Features of Campylobacter sputorum subsp. mucosalis subsp. nov., nom. rev. and Their Taxonomic Significance
  • Roop1985 - Campylobacter mucosalis (Lawson, Leaver, Pettigrew, and Rowland 1981) comb. nov.: Emended Description
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR CAMPYLOBACTER MUCOSALIS
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • ...............................
    • GENERAL REFERENCES FOR CAMPYLOBACTER MUCOSALIS
  • Bilen2018e - Description of the human gut microbiota by culturomics
    • Added: January 05, 2022